Traynor Capital Management’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Traynor Capital Management’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-661	Closed	-$6K	–	224
2022 Q1	$6K	Hold	661	–	–	﹤0.01%	204
2021 Q4	$14K	Hold	661	–	–	﹤0.01%	218
2021 Q3	$21K	Buy	+661	New	+$24.2K	﹤0.01%	198
2021 Q1	–	Sell	-667	Closed	-$43K	–	193
2020 Q4	$43K	Buy	+667	New	+$43.5K	0.01%	155

Other funds holding SRGA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AWS

Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return

CLG

Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Traynor Capital Management's SRGA Position: Q2 2022 in Review

Traynor Capital Management sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2022, closing a stake of 661 shares — an estimated $6K sold.

Traynor Capital Management first reported a position in SRGA in Q4 2020 and held it in 4 quarters. The position peaked at $43K in Q4 2020. 40 funds tracked by Wall St. Rank hold SRGA as of Q2 2022.

Traynor Capital Management reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Traynor Capital Management sold 661 Surgalign Holdings, Inc. Common Stock shares in Q2 2022, an estimated $6K.
Traynor Capital Management first reported a position in Surgalign Holdings, Inc. Common Stock in Q4 2020 and held it in 4 quarters.
Traynor Capital Management's Surgalign Holdings, Inc. Common Stock position peaked at $43K in Q4 2020.
40 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2022.

Based on Traynor Capital Management's 13F filing for Q2 2022, filed 28 Jul 2022.